| Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population J Sabin, S Urtiaga, B Pilo, I Thuissard, V Galan, SS de la Maza, ... Journal of neurology, 1-10, 2020 | 26 | 2020 |
| Adolescent with neuropsychiatric symptoms associated with novel influenza A (H1N1) virus infection M German-Diaz, R Pavo-Garcia, J Diaz-Diaz, E Giangaspro-Corradi, ... The Pediatric infectious disease journal 29 (6), 570-571, 2010 | 23 | 2010 |
| Focal status epilepticus: a review of pharmacological treatment. NG Huertas, AG Barros, VR Hernando, JD Díaz Neurologia (Barcelona, Spain), 2019 | 7* | 2019 |
| Manual de urgencias de pediatría MM Ferrer, OO Sáez, AP Cuesta Ergon, 2010 | 7 | 2010 |
| COVID-19 vaccination and humoral immune response in people with multiple sclerosis C Oreja-Guevara, CI Ramirez, E Alba-Suarez, I Gomez-Estevez, ... Multiple Sclerosis Journal, 728-728, 2021 | 5 | 2021 |
| Three-year effectiveness of dimethyl fumarate in multiple sclerosis: a prospective multicenter real-world study B Pilo de la Fuente, J Sabín, V Galán, I Thuissard, S Sainz de la Maza, ... CNS drugs 34, 1275-1286, 2020 | 5 | 2020 |
| Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis SS de la Maza, JS Muñoz, BP de la Fuente, I Thuissard, ... Multiple Sclerosis and Related Disorders 59, 103669, 2022 | 3 | 2022 |
| Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment M Gómez-Moreno, VG Sánchez-Seco, S Moreno-García, PS Cámara, ... Multiple Sclerosis and Related Disorders 49, 102747, 2021 | 3 | 2021 |
| Estatus epiléptico focal: revisión del tratamiento farmacológico NH González, AB González, VH Requejo, JD Díaz Neurología 37 (9), 757-766, 2022 | 2 | 2022 |
| Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients J Díaz-Díaz, CI Ramirez, M Ortiz-Pica, E García-Yusta, I Gómez-Estevez, ... Journal of the Neurological Sciences 429, 2021 | 2 | 2021 |
| Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019) JD Lünemann, J Diaz-Diaz, B Stankoff, C Young, A Siva, A Miller, ... Multiple Sclerosis Journal, 1352458520918377, 2020 | 2 | 2020 |
| Cobalt poisoning secondary to hip prothesis. J Lapena Motilva, PM de Lara Cadinanos, G Ogando Duran, J Diaz Diaz, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 931-932, 2019 | 2 | 2019 |
| Cerebral sinovenous thrombosis in children due to L-asparaginase JD Díaz, NE Nuñez, A de Aragón Martinez, ML Barrios, AS Camacho, ... Anales de pediatria (Barcelona, Spain: 2003) 82 (2), 113-114, 2015 | 2 | 2015 |
| Necrosis grasa subcutánea complicada tras tratamiento con hipotermia terapéutica por encefalopatía hipóxico-isquémica grave J Díaz Díaz, R Morante Valverde, D Muñoz, E Matí Carreras, ... Anales de Pediatría 81 (6), e36-e37, 2014 | 2 | 2014 |
| Cisplatin induced reversible posterior leukoencephalopathy JD Díaz, MD Germán, ML Barrios, ADA Martinez, RDLH Simón, ... Anales de pediatria (Barcelona, Spain: 2003) 77 (4), 281-282, 2012 | 2 | 2012 |
| 4-year follow-up of multiple sclerosis patients treated with cladribine: clinical outcomes and third-year course C Oreja-Guevara, I Gómez-Estévez, E Alba Suarez, J Quezada-Sanchez, ... European Journal of Neurology 29, 795-795, 2022 | 1 | 2022 |
| Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients C Oreja-Guevara, J Díaz-Díaz, EA Suárez, I Gómez-Estévez, JQ Sánchez, ... Multiple Sclerosis and Related Disorders 59, 2022 | 1 | 2022 |
| Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients C Oreja-Guevara, J Quezada-Sánchez, J Díaz-Díaz, I Gómez-Estévez, ... Multiple Sclerosis and Related Disorders 59, 2022 | 1 | 2022 |
| Baseline inflammatory status reveals dichotomic immune mechanisms involved in primary-progressive multiple sclerosis pathology JI Fernández-Velasco, E Monreal, J Kuhle, V Meca-Lallana, ... Frontiers in immunology, 1199, 2022 | 1 | 2022 |
| Management of intravenous therapy for MS during COVID-19 pandemic J Díaz-Díaz, CI Ramirez, E García-Yusta, M Ortiz-Pica, E Martinez-Perez, ... Multiple Sclerosis Journal, 647-647, 2021 | 1 | 2021 |
